{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:21:57Z","timestamp":1794442917029,"version":"4.9.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Graft versus host disease (GVHD) is an uncommon but highly morbid complication of intestinal transplantation (ITx). In this study, we reviewed our 17-y experience with GVHD focusing on factors predicting GVHD occurrence and survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Retrospective review of 271 patients who received 1 or more ITx since program inception in 2003 with survival analysis using Cox proportional hazard modeling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Of 271 patients, 28 developed GHVD 34 (18\u201366) d after ITx presenting with rash or rash with fever in 26, rectosigmoid disease in 1, and hemolysis in 1; other sites, mainly rectosigmoid colon, were involved in 13. Initial skin biopsy demonstrated classic findings in 6, compatible findings in 14, and no abnormalities in 2. Additional sites of GVHD later emerged in 14. Of the 28 patients, 16 died largely from sepsis, the only independent hazard for death (hazard ratio [HR], 37.4181; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.0008). Significant (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.0500) independent hazards for occurrence of GVHD in adults were pre-ITx functional intestinal failure (IF) (HR, 15.2448) and non-IF diagnosis (HR, 20.9952) and early post-ITx sirolimus therapy (HR, 0.0956); independent hazards in children were non-IF diagnosis (HR, 4.3990), retransplantation (HR, 4.6401), donor:recipient age ratio (HR, 7.3190), and graft colon omission (HR, 0.1886). Variant transplant operation was not an independent GVHD hazard.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Initial diagnosis of GVHD after ITx remains largely clinical, supported but not often confirmed by skin biopsy. Although GVHD risk is mainly recipient-driven, changes in donor selection and immunosuppression practice may reduce incidence and improve survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001187","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:00:57Z","timestamp":1626735657000},"page":"e731","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience"],"prefix":"10.1097","volume":"7","author":[{"given":"Stuart S.","family":"Kaufman","sequence":"first","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsadig","family":"Hussan","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kroemer","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Timofeeva","sequence":"additional","affiliation":[{"name":"Georgetown University School of Medicine, Washington, DC."},{"name":"Histocompatibility Laboratory, MedStar Georgetown University Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena B.","family":"Pasieka","sequence":"additional","affiliation":[{"name":"Georgetown University School of Medicine, Washington, DC."},{"name":"Department of Dermatology, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Uniformed Services University of the Health Sciences, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Guerra","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada A.","family":"Yazigi","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid M.","family":"Khan","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udeme D.","family":"Ekong","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Subramanian","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Hawksworth","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaelle","family":"Girlanda","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahira S.","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"MedStar Pharmacy, MedStar Georgetown University Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Fishbein","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cal S.","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC."},{"name":"Georgetown University School of Medicine, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/1744666X.2016.1145056","article-title":"Immunological basis for treatment of graft versus host disease after liver transplant.","volume":"12","author":"Rai","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jpedsurg.2009.10.071","article-title":"Graft-vs-host disease after small bowel transplantation in children.","volume":"45","author":"Andres","year":"2010","journal-title":"J Pediatr Surg"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1600-6143.2004.00524.x","article-title":"Graft versus host disease in intestinal transplantation.","volume":"4","author":"Mazariegos","year":"2004","journal-title":"Am J Transplant"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.transproceed.2009.05.030","article-title":"Acute graft-versus-host-disease in kidney transplantation: case report and review of literature.","volume":"41","author":"Kato","year":"2009","journal-title":"Transplant Proc"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease.","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1634\/theoncologist.2019-0627","article-title":"FDA approval summary: ruxolitinib for treatment of steroid-refractory acute graft-versus-host disease.","volume":"25","author":"Przepiorka","year":"2020","journal-title":"Oncologist"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bmt.2012.187","article-title":"Risk and prognostic factors for acute GVHD based on NIH consensus criteria.","volume":"48","author":"Lee","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1525-1470.2012.01839.x","article-title":"Cutaneous graft versus host disease in pediatric multivisceral transplantation.","volume":"30","author":"Feito-Rodr\u00edguez","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/TP.0b013e3181ff86ec","article-title":"Graft-versus-host disease after intestinal and multivisceral transplantation.","volume":"91","author":"Wu","year":"2011","journal-title":"Transplantation"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jpedsurg.2011.04.016","article-title":"Incidence of acute and chronic graft-versus-host disease and donor T-cell chimerism after small bowel or combined organ transplantation.","volume":"46","author":"Shin","year":"2011","journal-title":"J Pediatr Surg"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.transproceed.2015.11.007","article-title":"Graft-versus-host disease after intestinal or multivisceral transplantation: a Scandinavian single-center experience.","volume":"48","author":"Cromvik","year":"2016","journal-title":"Transplant Proc"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"98","DOI":"10.12659\/AOT.908052","article-title":"Challenges with intestine and multivisceral re-transplantation: importance of timing of re-transplantation and optimal immunosuppression.","volume":"23","author":"Kubal","year":"2018","journal-title":"Ann Transplant"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/petr.12211","article-title":"Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency.","volume":"18","author":"Fischer","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/pde.13840","article-title":"Impact of skin biopsy on the management of acute graft-versus-host disease in a pediatric population.","volume":"36","author":"Haimes","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1097\/TP.0000000000001131","article-title":"Severe skin complications after small bowel transplantation: graft-versus-host disease, DRESS, virus, or drug toxicity?","volume":"100","author":"Cruysmans","year":"2016","journal-title":"Transplantation"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1111\/ajt.13325","article-title":"Macrochimerism in intestinal transplantation: association with lower rejection rates and multivisceral transplants, without GVHD.","volume":"15","author":"Zuber","year":"2015","journal-title":"Am J Transplant"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/ajt.16405","article-title":"CD69+ resident memory T cells are associated with graft-versus-host disease in intestinal transplantation.","volume":"21","author":"Weiner","year":"2021","journal-title":"Am J Transplant"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra0804605","article-title":"Intestinal transplantation.","volume":"361","author":"Fishbein","year":"2009","journal-title":"N Engl J Med"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jpeds.2009.11.002","article-title":"Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy.","volume":"156","author":"Kaufman","year":"2010","journal-title":"J Pediatr"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.gtc.2018.01.011","article-title":"Adult intestinal transplantation.","volume":"47","author":"Matsumoto","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1600-6143.2012.04238.x","article-title":"Successful isolated intestinal transplantation in sensitized recipients with the use of virtual crossmatching.","volume":"12 Suppl 4","author":"Hawksworth","year":"2012","journal-title":"Am J Transplant"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/ajt.15269","article-title":"Long-term survival in visceral transplant recipients in the new era: a single-center experience.","volume":"19","author":"Elsabbagh","year":"2019","journal-title":"Am J Transplant"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5858\/arpa.2011-0596-RA","article-title":"Small-bowel allograft biopsies in the management of small-intestinal and multivisceral transplant recipients: histopathologic review and clinical correlations.","volume":"136","author":"Remotti","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOT.0000000000000624","article-title":"Current status of graft-versus-host disease after intestinal transplantation.","volume":"24","author":"Ganoza","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.det.2019.05.014","article-title":"Review of graft-versus-host disease.","volume":"37","author":"Ramachandran","year":"2019","journal-title":"Dermatol Clin"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/DAD.0000000000000357","article-title":"Histopathologic features of cutaneous acute graft-versus-host disease in T-cell-depleted peripheral blood stem cell transplant recipients.","volume":"37","author":"Fischer","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/cup.13326","article-title":"Clinical and histopathologic manifestations of solid organ transplantation-associated graft-versus-host disease involving the skin: a single-center retrospective study.","volume":"45","author":"Kim","year":"2018","journal-title":"J Cutan Pathol"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.humpath.2010.07.004","article-title":"The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo.","volume":"42","author":"Massi","year":"2011","journal-title":"Hum Pathol"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cup.12427","article-title":"Acute cutaneous graft-vs.-host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features.","volume":"42","author":"Lehman","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"suppl 9","key":"R30-20240805","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbmt.2008.05.001","article-title":"Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.","volume":"14","author":"Spellman","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood-2006-06-032193","article-title":"HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.","volume":"109","author":"Wade","year":"2007","journal-title":"Blood"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"e13409","DOI":"10.1111\/ctr.13409","article-title":"Post-intestine transplant graft-vs-host disease associated with inclusion of a liver graft and with a high mortality risk.","volume":"33","author":"Clouse","year":"2019","journal-title":"Clin Transplant"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jcmm.12093","article-title":"Advances in the treatment of acute graft-versus-host disease.","volume":"17","author":"Qian","year":"2013","journal-title":"J Cell Mol Med"},{"key":"R34-20240805","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bbmt.2007.06.013","article-title":"High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.","volume":"13","author":"Labb\u00e9","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R35-20240805","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bmt.2009.39","article-title":"Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.","volume":"44","author":"Mikulska","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"R36-20240805","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/TP.0b013e31817b912e","article-title":"Refractory graft versus host disease after pediatric intestinal transplantation-beware of pre-existing immunodeficiency.","volume":"86","author":"Davison","year":"2008","journal-title":"Transplantation"},{"key":"R37-20240805","doi-asserted-by":"crossref","first-page":"e141698","DOI":"10.1172\/JCI141698","article-title":"Lymphohematopoietic graft-versus-host responses promote mixed chimerism in patients receiving intestinal transplantation.","volume":"131","author":"Fu","year":"2021","journal-title":"J Clin Invest"},{"key":"R38-20240805","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1651-2227.1997.tb14811.x","article-title":"Immune deficiencies in chronic intestinal pseudo-obstruction.","volume":"86","author":"Forchielli","year":"1997","journal-title":"Acta Paediatr"},{"key":"R39-20240805","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3389\/fimmu.2018.01036","article-title":"Combined immunodeficiency in patients with trichohepatoenteric syndrome.","volume":"9","author":"V\u00e9ly","year":"2018","journal-title":"Front Immunol"},{"key":"R40-20240805","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jcmgh.2018.12.001","article-title":"TTC7A: steward of intestinal health.","volume":"7","author":"Jardine","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R41-20240805","first-page":"20143085","article-title":"Evolution of the immune system in humans from infancy to old age.","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"R42-20240805","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/ctr.12627","article-title":"Graft-versus-host disease after orthotopic liver transplantation: multivariate analysis of risk factors.","volume":"29","author":"Elfeki","year":"2015","journal-title":"Clin Transplant"},{"key":"R43-20240805","first-page":"886","article-title":"Addition of the colon to small bowel grafts causes lethal graft-versus-host disease in FK 506-treated pigs.","volume":"28","author":"Pirenne","year":"1996","journal-title":"Transplant Proc"},{"key":"R44-20240805","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4253\/wjge.v6.i11.534","article-title":"Nodular lymphoid hyperplasia in the gastrointestinal tract in adult patients: a review.","volume":"6","author":"Albuquerque","year":"2014","journal-title":"World J Gastrointest Endosc"},{"key":"R45-20240805","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MOT.0b013e3283467102","article-title":"Inclusion of the colon in intestinal transplantation.","volume":"16","author":"Matsumoto","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"R46-20240805","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00007890-199112000-00002","article-title":"Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration.","volume":"52","author":"Shaffer","year":"1991","journal-title":"Transplantation"},{"key":"R47-20240805","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2010.03210.x","article-title":"Immune reconstitution following rabbit antithymocyte globulin.","volume":"10","author":"Gurkan","year":"2010","journal-title":"Am J Transplant"},{"key":"R48-20240805","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.transproceed.2007.02.067","article-title":"Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation.","volume":"39","author":"Lauro","year":"2007","journal-title":"Transplant Proc"},{"key":"R49-20240805","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.transproceed.2016.11.001","article-title":"Association of the number of HLA-DR mismatches with early post-transplant acute cellular rejection among heart transplantation recipients: a cohort study in Japanese population.","volume":"49","author":"Nitta","year":"2017","journal-title":"Transplant Proc"},{"key":"R50-20240805","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0012.2001.150308.x","article-title":"Prospective study of microchimerism in renal allograft recipients: association between HLA-DR matching, microchimerism and acute rejection.","volume":"15","author":"Tajik","year":"2001","journal-title":"Clin Transplant"},{"key":"R51-20240805","doi-asserted-by":"crossref","first-page":"e13836","DOI":"10.1111\/petr.13836","article-title":"Efficacy and feasibility of ruxolitinib in chronic steroid-refractory GVHD in a pediatric intestine transplant.","volume":"25","author":"Ghobrial","year":"2021","journal-title":"Pediatr Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:07:53Z","timestamp":1722834473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001187","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]}}}